Please select the eligibility criteria that correspond to the clinical trial below.
Title: Hatha Yoga for Patients With Colorectal Cancer - a Randomized Controlled Trial
Brief Summary: Hatha Yoga is a traditional practice that encompasses aerobic exercise, breathing techniques, and meditation. It is used in India since centuries to improve well-being and cope with diseases and is gaining more and more interest in Europe and the US. While studies have demonstrated benefits of Hatha Yoga for patients with breast cancer, no studies on patients with colorectal cancer are available yet. The purpose of this study is to investigate the effect of Hatha Yoga in patients with colorectal cancer.


Options:
A: Inclusion Criteria:

* stage I-III colon or rectal adenocarcinoma
* completed standard cytotoxic chemotherapy if medically indicated
* be considered disease-free at baseline
* be able to speak and read English
* have no contra-indication to moderate to vigorous aerobic exercise
* be able to walk unassisted
* be inactive at baseline (\<150 min/week of moderate physical activity)
* have access to a mobile phone
* be able to navigate websites, fill out forms on the web, communicate by email, and have regular access to the internet
B: Inclusion Criteria:

* Colorectal cancer
* UICC stage I-III
* between 2 and 48 months post-surgery
* age at least 18 years
* physical and cognitive ability to follow the yoga intervention

Exclusion Criteria:

* UICC stage IV
* further active oncological diseases
* diagnosed and pharmacologically treated psychiatric disorder except for cancer-related depression or adjustment disorder
* pregnancy or breastfeeding
C: Inclusion Criteria:

* Newly diagnosed with breast cancer,
* colorectal cancer,
* lymphoma,
* prostate cancer or testicle cancer and scheduled for adjuvant and/or curative treatment in the form of chemotherapy, radiation therapy and/or hormonal therapy at the Department of Oncology and Medical physics, Haukeland University Hospital, (Dept. of Oncology) Bergen,
* residence in Rogaland, Hordaland and Sogn and fjordane county council,
* initial treatment for cancer

Exclusion Criteria:

* An ongoing psychiatric condition,
* language deficiencies in Norwegian,
* surgery for prostate cancer (only applies for prostate cancer) patients),
* men with breast cancer,
* live in nursing homes,
* previous cancer,
* treated for cancer earlier,
* already implemented oncological treatment,
* not self-reliant
D: DISEASE CHARACTERISTICS:

* Survivor of breast, prostate, colon, lung, lymphoma, ovarian, bladder, or esophageal cancer with no evidence of disease
* At least moderate levels of fatigue and/or weakness
* Impaired mobility but ambulatory and medically able to participate in an exercise regimen

  * No impaired knee flexion, defined as \< 90º

PATIENT CHARACTERISTICS:

* Folstein Mini-Mental Status Examination score ≥ 23
* No extreme claustrophobia
* No diagnosed chronic fatigue syndrome/disorder
* No neurological impairments, including the following:

  * Central nervous system disorder (e.g., multiple sclerosis or Parkinson's disease)
  * Neurological insult (cerebrovascular attack) that manifests in a mobility disorder
* No myopathic disease (e.g., focal myopathy) that effects skeletal muscle structure/function
* No rheumatological disease that has an effect on muscle and/or mobility (e.g., polymyalgia rheumatica)

PRIOR CONCURRENT THERAPY:

* More than 6 months since prior regular aerobic or resistance exercise

  * Regular exercise defined as 2-3 times per week
* At least 6 months since prior cancer treatment (surgery, radiation, and/or chemotherapy )
* No concurrent cancer-related treatment other than hormonal therapy

Answer: B